We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (383)
- Scheduling (national classification system) (164)
- Safety monitoring and information (26)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Medicinal cannabis hub (6)
- Clinical trials (5)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
758 result(s) found, displaying 226 to 250
-
Meeting statementsAdvisory Committee on Medicines meeting statement, Out of Session Meeting, 26 April 2022
-
Meeting statementsAdvisory Committee on Medicines meeting statement, Meeting 33, 2-3 June 2022
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 24 November 2022
-
Corporate reportsOverview of therapeutic goods advertising complaints handling and compliance for 2021-22
-
Meeting statementsThe Australian Influenza Vaccine Committee (AIVC) recommendations for the composition of influenza vaccine for Australia in 2023
-
Meeting statementsA meeting of the Therapeutic Goods Advertising Consultative Committee was held on 17 August 2022.
-
Corporate reportsThis report was commissioned by the TGA in response to concerns of increasing prevalence of intentional paracetamol poisoning, especially among young people, and involving paracetamol obtained via general sale in supermarkets and convenience stores.
-
Scheduling decisions (final)Notification of amendments to the Poisons Standard in relation to Delegate-only final decisions and New Chemical Entities (NCEs), September 2022
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement, Meeting 68, 11 August 2022
-
Meeting statementsAdvisory Committee on Medical Devices (ACMD) meeting statement, Meeting 67, 9 June 2022
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 32, 22 March 2022
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 33, 20 May 2022
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 15 September 2022
-
Meeting statementsMeeting statement from meeting 7 of the MDCWG.
-
Meeting statementsA meeting statement from the fourth meeting of the Dental Sector Working Group is now available.
-
Corporate reportsThe report has been published, including MTP Connect's major findings and TGA's proposed response to the major recommendations.
-
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 17 March 2022
-
Corporate reportsPrescription opioid tracking research
-
Scheduling decisions (final)Notification of final decisions in relation to matters considered at ACMS #36, ACCS #32 and Joint ACMS-ACCS #29 (November 2021).
-
Scheduling decisions (final)Final decision on proposed amendments to the Poisons Standard relating to isothiazolinones, methylisothiazolinone and methylchloroisothiazolinone
-
Meeting statementsAdvisory Committee on Medical Devices (ACMD) meeting statement, Meeting 66, 7 April 2022.
-
Meeting statementsA meeting statement from the third meeting of the Dental Sector Working Group is now available.
-
Meeting statementsMeeting statement from meeting 5 of the MDCWG.
-
Meeting statementsMeeting statement from meeting 6 of the MDCWG.